The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies
- 31 December 1993
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (6) , 926-927
- https://doi.org/10.1016/s0959-8049(05)80444-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Thrush Can Be Prevented in Patients With Acquired Immunodeficiency Syndrome and the Acquired Immunodeficiency Syndrome—Related ComplexArchives of internal medicine (1960), 1991
- Chemoprophylaxis of Fungal Infections in Granulocytopenic Patients Using Fluconazole vs Oral Amphotericin BClinical Drug Investigation, 1991
- Imipenem‐cilastatin for empirical therapy in neutropenic patients with fever: An open study in patients with hematologic malignanciesEuropean Journal of Haematology, 1991
- Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1990
- Infection Prophylaxis in Acute LeukemiaArchives of internal medicine (1960), 1984
- Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the twoArchives of internal medicine (1960), 1984
- Prevention of Infection by Trimethoprim-Sulfamethoxazole Plus Amphotericin B in Patients with Acute Nonlymphocytic LeukaemiaAnnals of Internal Medicine, 1981